INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 国立研究開発法人国立がん研究センター, MEDINET CO., LTD., 株式会社メディネット FILES APPLICATION FOR "T-CELL RECEPTOR FOR RECOGNIZING COMPLEX OF HSP105-DERIVED PEPTIDE AND MHC CLASS I MOLECULE AND METHOD FOR USING SAME"

Posted On: 2025-12-09

GENEVA, Dec. 9 -- NATIONAL CANCER CENTER (1-1, Tsukiji 5-chome, Chuo-ku, Tokyo1040045), 国立研究開発法人国立がん研究センター (東京都中央区築地五丁目１番１号), MEDINET CO., LTD. (1-5-21 Katsushima, Shinagawa-ku, Tokyo1400012), 株式会社メディネット (東京都品川区勝島一丁目５番２１号) filed a patent application (PCT/JP2025/019570) for "T-CELL RECEPTOR FOR RECOGNIZING COMPLEX OF HSP105-DERIVED PEPT...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 国立研究開発法人国立がん研究センター, MEDINET CO., LTD., 株式会社メディネット FILES APPLICATION FOR "T-CELL RECEPTOR FOR RECOGNIZING COMPLEX OF HSP105-DERIVED PEPTIDE AND MHC CLASS I MOLECULE AND METHOD FOR USING SAME"